PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system

被引:30
|
作者
Castillo, Paula M. [1 ,2 ,3 ]
de la Mata, Mario [4 ]
Casula, Maria F. [1 ,2 ]
Sanchez-Alcazar, Jose A. [4 ]
Zaderenko, Ana P. [3 ]
机构
[1] Univ Cagliari, INSTM, I-09124 Cagliari, Italy
[2] Univ Cagliari, Dipartimento Sci Chim & Geol, I-09124 Cagliari, Italy
[3] Univ Pablo Olavide, Dept Sistemas Fis Quim & Nat, Seville, Spain
[4] Univ Pablo Olavide, CSIC, CABD, Ctr Andaluz Biol Desarrollo, Seville, Spain
来源
关键词
camptothecin; cancer therapy; iron oxide superparamagnetic nanoparticles; polyethylene glycol; IRON-OXIDE NANOPARTICLES; DRUG-DELIVERY; IN-VIVO; CYCLODEXTRIN-COMPLEXATION; TOPOISOMERASE-I; CONTRAST AGENTS; THERAPY; PHASE; DESIGN; CYTOTOXICITY;
D O I
10.3762/bjnano.5.144
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Camptothecin (CPT; (S)-(+)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione) is a highly cytotoxic natural alkaloid that has not yet found use as chemotherapeutic agent due to its poor water-solubility and chemical instability and, as a consequence, no effective administration means have been designed. In this work, camptothecin has been successfully loaded into iron oxide superparamagnetic nanoparticles with an average size of 14 nm. It was found that surface modification of the nanoparticles by polyethylene glycol enables loading a large amount of camptothecin. While the unloaded nanoparticles do not induce apoptosis in the H460 lung cancer cell line, the camptothecin-loaded nanoparticle formulations exhibit remarkable proapoptotic activity. These results indicate that camptothecin retains its biological activity after loading onto the magnetic nanoparticles. The proposed materials represent novel materials based on naturally occurring bioactive molecules loaded onto nanoparticles to be used as chemotherapeutic formulations. The procedure seems apt to be extended to other active molecules extracted from natural products. In addition, these materials offer the potential of being further implemented for combined imaging and therapeutics, as magnetic nanoparticles are known to be multifunctional tools for biomedicine.
引用
收藏
页码:1312 / 1319
页数:8
相关论文
共 50 条
  • [1] PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
    Castillo, Paula M.
    de la Mata, Mario
    Casula, Maria F.
    Sánchez-Alcázar, José A.
    Zaderenko, Ana P.
    Beilstein Journal of Nanotechnology, 2014, 5 (01) : 1312 - 1319
  • [2] Shrinkage of pegylated and non-pegylated liposomes in serum
    Wolfram, Joy
    Suri, Krishna
    Yang, Yong
    Shen, Jianliang
    Celia, Christian
    Fresta, Massimo
    Zhao, Yuliang
    Shen, Haifa
    Ferrari, Mauro
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2014, 114 : 294 - 300
  • [3] Comparison of PEGylated and non-PEGylated proticles: An in vitro and in vivo study
    Fresacher, Katja
    Helbok, Anna
    Reiser, Martin
    Blass, Sandra
    Rangger, Christine
    Mair, Christian
    von Guggenberg, Elisabeth
    Decristoforo, Clemens
    Andreae, Fritz
    Zimmer, Andreas
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 139
  • [4] OCULAR TISSUE DISTRIBUTION OF TOPICALLY APPLIED PEGYLATED AND NON-PEGYLATED LIPOSOMES
    Nasir, Nurul Alimah Abdul
    Alyautdin, Renad Nikolaevich
    Agarwal, Renu
    Nukolova, Natalia
    Cheknonin, Vladimir
    Ismail, Nafeeza Mohd
    NANOSCIENCE, NANOTECHNOLOGY AND NANOENGINEERING, 2014, 832 : 1 - +
  • [5] Synthesis and Characterization of Poly (β-amino Ester) and Applied PEGylated and Non-PEGylated Poly (β-amino ester)/Plasmid DNA Nanoparticles for Efficient Gene Delivery
    Iqbal, Sajid
    Martins, Alessandro F.
    Sohail, Muhammad
    Zhao, Jingjing
    Deng, Qi
    Li, Muhan
    Zhao, Zhongxi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] PEGylated and Non-PEGylated TCP-1 Probes for Imaging of Colorectal Cancer
    Liu, Zhonglin
    Gray, Brian D.
    Barber, Christy
    Wan, Li
    Furenlid, Lars R.
    Liang, Rongguang
    Li, Zheng
    Woolfenden, James M.
    Pak, Koon Y.
    Martin, Diego R.
    MOLECULAR IMAGING AND BIOLOGY, 2023, 25 (01) : 133 - 143
  • [7] PEGylated and Non-PEGylated TCP-1 Probes for Imaging of Colorectal Cancer
    Zhonglin Liu
    Brian D. Gray
    Christy Barber
    Li Wan
    Lars R. Furenlid
    Rongguang Liang
    Zheng Li
    James M. Woolfenden
    Koon Y. Pak
    Diego R. Martin
    Molecular Imaging and Biology, 2023, 25 : 133 - 143
  • [8] PEGylated versus non-PEGylated drugs: A cross-sectional analysis of adverse events in the FDA Adverse Event Reporting System (FAERS) Database
    Zhu, Zhengyi
    Gao, Peng
    Hu, Yan
    Wang, Junyan
    Wang, Huijuan
    Yang, Jufei
    Huang, Lingfei
    Ji, Cai
    Ni, Yinghua
    Fang, Luo
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (06) : 332 - 342
  • [9] PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study
    Nunes, Shirleide Santos
    Silva, Juliana de Oliveira
    Fernandes, Renata Salgado
    Miranda, Sued Eustaquio Mendes
    Leite, Elaine Amaral
    de Farias, Marcelo Alexandre
    Portugal, Rodrigo Villares
    Cassali, Geovanni Dantas
    Townsend, Danyelle M.
    Oliveira, Monica Cristina
    de Barros, Andre Luis Branco
    PHARMACEUTICS, 2022, 14 (02)
  • [10] Postmarketing hepatic adverse event experience with PEGylated/non-PEGylated drugs: a disproportionality analysis
    Hauben, Manfred
    Vegni, Ferdinando
    Reich, Lester
    Younus, Muhammad
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (11) : 934 - 941